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Abstract
Background
Multimorbidity, according to the World Health Organization, exists when there are two or
more chronic conditions in one patient. This definition seems inaccurate for the holistic
approach to Family Medicine (FM) and long-term care. To avoid this pitfall the European
General Practitioners Research Network (EGPRN) designed a comprehensive definition of
multimorbidity using a systematic literature review.
Objective
To translate that English definition into European languages and to validate the semantic,
conceptual and cultural homogeneity of the translations for further research.
Method
Forward translation of the EGPRN’s definition of multimorbidity followed by a Delphi con-
sensus procedure assessment, a backward translation and a cultural check with all teams
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to ensure the homogeneity of the translations in their national context. Consensus was de-
fined as 70% of the scores being higher than 6. Delphi rounds were repeated in each coun-
try until a consensus was reached
Results
229 European medical expert FPs participated in the study. Ten consensual translations of
the EGPRN comprehensive definition of multimorbidity were achieved.
Conclusion
A comprehensive definition of multimorbidity is now available in English and ten European
languages for further collaborative research in FM and long-term care.
Introduction
The concept of multimorbidity was first published in 1976 [1] in Germany and remained al-
most entirely restricted to German publications for 14 years. Between 1976 and 1990 only
72 articles used the term multimorbidity in their text, of which 66 were written in German. In
1990 the concept became internationally recognized through research [2].
The concept of multimorbidity was an addition to the concept of comorbidity. Comorbidity
was defined as any disease or risk factors that could interact with one main disease with the ef-
fect of making it worse [3–5]. Multimorbidity has been defined by the World Health Organiza-
tion (WHO) as people being affected by two or more chronic health conditions [6]. The
intention of the WHO was to look at all conditions in one individual that could impact on that
individual’s global health status. However the word ‘condition’ was not sufficiently clear for
practical purposes (for instance, whether a treated disease was a ‘condition’ in this sense), and
could lead to numerous interpretations.
Multimorbidity is a very interesting and challenging concept particularly for Family Medi-
cine and long term care, given the increasing prevalence of chronic illness in an aging popula-
tion across all developed countries. It is closely related to a global or comprehensive view of the
patient, which is a core competency of Family Medicine (FM), as defined for instance by the
World Organization of National Colleges, Academies and Academic Associations of General
Practitioners/Family Physicians (WONCA) [7]. It is a global ‘functional’ view (useful for
Long-Term Care) versus a ‘disease’ centered point of view (useful for acute care) [8]. It is also a
very interesting concept, when applied to patients, as it gives a global overview of all the factors
that could lead to frailty [9–10]. Frailty is a new concept, formulated to help physicians identify
decompensating patients. Its link with multimorbidity has already been discussed [11] and a
call to action for a consensus on Frailty has been formulated[12].
The European General Practice Research Network (EGPRN) is committed to concepts that
could advance research in primary care throughout Europe. The EGPRN has created a research
agenda specifically designed for methodological and instrumental research, which includes the
development of primary care epidemiology, focusing on patient-centered health [13]. A clear
definition of the concept of multimorbidity (i.e. one which is both understandable and usable
for further collaborative research) is an important objective for a research network of this type.
It will help researchers in FM to investigate the complexity of patients’ conditions and their
overall impact on patients’ health. This definition of multimorbidity could be an additional
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tool for Family Physicians (FPs), enabling them to identify frail patients and prevent
decompensation.
A research team, including 9 national groups, all active within the EGPRN, has created a re-
search community for the purpose of clarifying the concept of multimorbidity for FM through-
out Europe [14]. An initial review, presented in an EGPRNmeeting in spring 2011 [15],
identified more than one hundred different definitions used by academic researchers. Such a
large number of definitions added more confusion than clarification to the discussion. It led
the group to the production of a comprehensive definition of multimorbidity through a sys-
tematic review of literature, in which all multimorbidity criteria were scanned and classified by
theme [16]. That comprehensive definition of multimorbidity was published after a careful
check of its wording and meaning by a working group of three MD researchers from the Irish
College of General Practitioners, an MD researcher from the Malta College of Family Doctors
and two native English speaking official translators from the University of Brest (France). [16]
This definition had then to be translated into most European languages for use in further
collaborative research. It has been previously demonstrated that translating definitions, index
or scales is a risky task in medical science[17]. The challenge is to establish a cultural homoge-
neity between the translations in order to ensure a qualitative transfer of content and that task
is as difficult in the medical sciences as it is in literature[18]. The purpose of this research was
to translate the exhaustive definition of multimorbidity into ten European languages with the
help of a multinational team, with the objective of maintaining a strong homogeneity across
those translations.
Materials and Methods
Maintaining homogeneity between translations needed a cautious and step by step method
[19–21]. For all participating countries (Bosnia, Bulgaria, Croatia, France, Germany, Greece,
Italy, Poland, Spain) the forward and backward translation of the original English definition
has been assessed using a Delphi consensus procedure [22].
Ethics Statement
The study was approved by the ethics committee of the University de Bretagne Occidentale.
The participants provided their written informed consent to participate in the study. The ethics
committee approved the consent procedure.
Research team
First, a research team (including several medical researchers and official translators for each
country) was asked to translate the definition from English into their native language. For
Spain and Catalonia, a double-language team was used as Catalan is a regional language of
Spain.
Participant selection
The next stage was to send the English multimorbidity definition and its native translation by
email to a group of at least 10 and, if possible, 30 national expert FPs. Variations in the sample
size were due to the limited number of such experts in small countries and the need to have a
larger purposive sample, if possible, allowing a less tentative interpretation of results. As the
Delphi technique is a qualitative method, the samples needed to be comparable in terms of ho-
mogeneity but not in terms of representativeness. Nevertheless, the Delphi technique is valid,
in terms if its effect on outcomes, irrespective of sample size, [23–24]. The study’s scientific
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committee stressed the role of gender, experience, age, level of English and research or teaching
activities to determine their selection. Each participant was contacted separately using emails
to avoid contamination, according to the methodology for the Delphi procedure [24].
Data collection
FromMay 2012 to December 2012 all experts were then asked to assess the equivalence of the
translations on a scale from 1 (absolutely no agreement) to 9 (full agreement) and had to write
down their remarks and opinions for each translation ranked below 7. Consensus was defined
as at least 70% of the participants rating the consensual definition at 7 or above. This definition
of consensus in a Delphi round is the strongest possible definition, according to the Delphi
methods, and the RAND UCLA method that is a modified Delphi technique [25]. The RAND
UCLA is accepted as a strong formal consensus methodology by Health agencies, such as the
NHS in the UK and the Agency for Healthcare Research and Quality in the US[25–26]. This
process, called a Delphi round, had to go on until a consensus was achieved. Between each
round all discordances had to be taken into account. All suggestions and remarks made by the
experts were incorporated into the translation with the objective of defining a new version for
the next round. Once the consensual definition in the native language had been established,
two other translators did a backward translation from the native language into English.
Data Analysis
These English consensual back translations had to be examined in order to ensure their seman-
tic and conceptual homogeneity by the study’s scientific committee which consisted of four
professors of Family Medicine, one associate professor in public health and one associate pro-
fessor in Family Medicine drawn from Belgium, France and The Netherlands. The national ori-
gins of these researchers could have influenced the outcomes. However, this possible bias was
limited as all were experienced researchers and published authors drawn from various coun-
tries, in order to ensure heterogeneity, as well as experts in scientific and medical English.
Changes could be instigated at that point, depending on the advice of the scientific committee.
To ensure cultural homogeneity, they were then analysed by the research group which un-
dertook a cultural check [27–28]. It was an iterative procedure including a physical meeting in
May 2013 during the EGPRNmeeting in Kusadasi (Turkey) and exchanges by e-mail before
and after the meeting to prepare data and validate the results. The group was composed of all
the team leaders and an English linguist from the University of Torun (Poland). English speak-
ing countries had no role to play in the translation into the other European languages. English
native speakers were, however, essential to the checking process which followed the backward
translations. As a possible loss of meaning could have occurred, the wording and meanings of
those backward translations were double-checked by using two native English speakers, official
translators from the University of Brest (France), before the cultural check took place. The cul-
tural check needed to take into account that some language conventions (affirmative or passive
voice, for example) could express the same meaning within two languages. It had to be very
cautious about:
• The control of the study quality throughout the follow-up to the research process which was
confirmed by the national team’s leaders and the scientific committee of the study
• The decision to look carefully at changes in meaning and especially at concepts within the
translations using tables to help comparison between translations
• The control of the quality of each final translation as the expression of all the concepts in the
original language, using tables to record discordances and each participant’s comment.
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• The synthesis of all the translations in order to compare them. Their presentation to the re-
search group used tables for all translations, all changes and all comments.
Depending on the result of the cultural check, some changes in the definition’s phrasing
were undertaken to ensure homogeneity within the definitions. As no English speaking country
was involved in the research process for the English consensual back translations, the wording
and meanings were double-checked by using two native English speakers, official translators
from the University of Brest (France) after the cultural check. Then all final translations and
their backward translations were sent for agreement to the study’s scientific committee.
Results
Sample
Participants
The nine teams in the different countries consisted of 12 to 30 members. In total there was a
good gender distribution, having a mean age of 48 years and on average 18 years of practice ex-
perience. All team members had reasonable experience of English usage (in speech, reading
and writing). The number of their publications in English averaged 5,91. (See Table 1).
Number of rounds
Countries needed one to two Delphi rounds to achieve their translations. When two rounds
were needed, it was mainly the result of experts’ confusion. In those countries the experts
thought they could discuss the definition itself. After a formal explanation of their task, the
rounds were successful. Even where all the consensus scores were high, the lower they were, the
more comments were expressed, as expected by this method. Comments were numerous ex-
pressing the richness of the exchanges. (See Table 2).
Analysis
Challenged terms
The terms which were challenged the most within Europe during translation were:
• Social network
• Burden of disease
Table 1. Expert Panel Characteristics.
COUNTRY Gender Average Age
in years
Average years of
practice
Competence in English Average English
publications
Other
publications
Total N = 229 M F Read Spoken Written
1 Bosnia N = 14 5 9 43,29 16,71 All All All 2,79 8,43
2 Bulgaria N = 30 11 19 47,03 21,8 All All All 0,27 1
3 Croatia N = 23 3 20 50,13 23,43 All All All 14,57 51,3
4 France N = 30 18 12 47,43 19,17 All All All 3,23 16,57
5 Germany N = 30 21 9 56,46 18,97 All All All 1,5 6,37
6 Greece N = 30 18 12 45,67 12,63 All All All 10,2 61,22
7 Italy N = 30 19 11 50,7 24,17 All All All 4,38 19
8 Poland N = 30 15 15 43,67 12,2 All All All 1,75 6,27
9 Spain N = 12 8 4 48,33 22,58 All All All 15,33 6
Global Average 50,69% 49,31% 48,26 18,82 100% 5,91 20,45
doi:10.1371/journal.pone.0115796.t001
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• Health care consumption
• Modifiers
• Health outcomes
• Frailty
• Biopsychosocial factors
Grammatical rewording suggestions were frequent. All comments were carefully recorded,
even where consensus had been obtained, in order to help the cultural check.
Backward translation
Backward translations were finalized and sent to the original authors of the definition. The au-
thors validated the translated definitions using the backward translations to check that there
were no semantic or conceptual changes in comparison with the original English definition.
Cultural check
The final phase was the cultural check to ensure the transculturality and homogeneity of the
translated definitions.
For Bosnia, the translated definition was not different from the original one despite the fact
that the phrases often involved the inversion of subject and complement. Some articles were
added to the original definition (“a chronic disease” instead of “chronic disease”) with a little
more stress placed on the presence of one chronic disease in a multimorbid patient. The group
concluded that there was no change in meaning.
For Bulgaria, some articles were added to the original translation (“a chronic disease” in-
stead of “chronic disease”) with the same meaning as the Bosnian changes. The group conclud-
ed that there was no change in meaning. There was a change concerning ‘connection’ instead
of ‘association’ (bio psychosocial factors “connected or not with the disease” instead of “associ-
ated or not with the disease”). But there is only one word in Bulgarian to express those two
meanings and the group concluded that there was no change of meaning. The “somatic risk
factors” were changed to “risk factors” as risk factors are always understood as somatic by
Table 2. Number of Delphi Rounds and Number of Comments in Each Country.
Country Number of Delphi
rounds
Mean consensus score for ﬁnal
Round
Number of score>6 as
percentage
Total number of
comments
Bosnia 2 7,8 100% 27
Bulgaria 1 8,2 96,67% 6
Croatia 1 8,5 100,00% 7
France 2 7,4 80.00% 63
Germany 2 7,8 81,00% 23
Greece 1 8,3 100,00% 6
Italy 1 7,6 80.00% 18
Poland 1 7,56 83.33% 9
Spain 1 7,08 75.00% 12
Catalonia 1 7,25 75.00% 12
Mean for
Europe
1.3 7,895 96% 18,3
doi:10.1371/journal.pone.0115796.t002
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Bulgarian FPs. The Bulgarians changed ‘network’ into ‘social network’, when describing the pa-
tient’s environment, to be sure the concept was as broad as in the original English definition. In
this way, they encompassed, in Bulgarian, not only family and friends (which is the meaning of
network in Bulgarian) but also the social infrastructures surrounding the patient, as was in-
tended in English. They modified « may modify the health outcomes » to “Multimorbidity can
lead to a change in the health outcomes”. This phrasing is less emphatic than the original. Nev-
ertheless, the research group did not think that the meaning was radically changed and kept
the Bulgarian version.
For Catalonia there was the same difference as in Bulgaria, regarding the use of articles.
There was no difference in meaning.
For Croatia, the “somatic” risk factor was present in the first sentence of the definition but
not in the second. The explanation was different from Bulgarian, as the Croatians did not want
to repeat the same item twice, seeing it as an underlying factor. All the articles in the second
paragraph were omitted as the Croatians wanted to simplify the definition, the way it should be
in their language. The group concluded that there were no differences in meaning.
For France, there was the same difference as in Bulgaria, regarding the use of articles, and
turning the second paragraph the other way round, with the same explanations. “The effects of
multimorbidity may be modified by” instead of “may function as modifiers (of the effects of
Multimorbidity).” There was no difference in meaning.
For Germany, there were some significant changes as the backward translation did not re-
flect the German version. As an example, the word ‘condition’ appears in the first sentence of
the backward translation and “Erkrankung” which means ‘disease’ is the only one used in the
German version. The back translation was corrected by another team of linguists and the only
difference was the affirmative phrasing in German with no use of the conditional tense. This
loss of the conditional tense is cultural in spoken German so this was accepted because this def-
inition is intended to be understood by everyone, including patients. There was a final differ-
ence between “reduced quality of life” instead of “decreased quality of life” which seemed
unchanged in meaning for the research group.
For Greece, there were many differences in relation to an affirmative phrasing in the Greek
language (even more so than in German) with the use of “can” instead of “may” which was ac-
cepted as it there is no difference in meaning in Modern Greek. The “health service use” oc-
curred instead of the “health service consumption” due to the fact that in Greek the word
consumption has the meaning of spending or expenditure and was better encompassed by
“use”.
For Italy, the use of “can be defined” instead of “is defined” comes from the fact that Italians
did not use “is defined”, preferring to express this idea by using ‘can be defined’ or “may be de-
fined” with the verb “potere” (being able to). The use of “chronic illness” instead of “chronic
disease” came from the point that “malattia” in Italian carries both meanings. The same diffi-
culty with the use of articles was observed as in Bulgaria and in France. The word “ogni” in Ital-
ian could be translated as ‘any’ or ‘every,’ with no change in meaning, and defines a more
global point of view which does not change the meaning of the sentence. A “worsening quality
of life” occurred instead of a “decreased quality of life” which encompassed a more affirmative
idea or greater fear about multimorbidity in Italy. This seems to be due to the greater presence
of multimorbidity in Italian practice which leads to a more active phrasing.
For Poland, the same difference with the use of articles was observed as in Bulgaria, France
and Italy. The use of “related” instead of “associated” looked stronger but did not change the
meaning and was accepted. There was the same difficulty with ‘risk factor’ instead of ‘somatic
risk factors’ as in Bulgaria, with the same underlying meaning pointing to the same conclusion.
The “use of health care services” replaced ‘health care consumption,” as in Greece, but for a
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different reason which is the lack of available medication, an additional factor in health services
in Poland. The Polish translators forgot the second part of the sentence at the end of the second
paragraph (‘of the effects of multimorbidity’) but this was added in the final definition. Then
‘weakness’ replaced ‘frailty’ as there is only one word for the two concepts in Polish.
For Spain and Catalonia there was the same difference as in Bulgaria, regarding the use of
articles. There was no difference in meaning.
The necessary changes were integrated into the final definitions and proposed to the study’s
scientific committee. The committee found no semantic, conceptual or cultural changes com-
pared with the original definition and so the translations obtained were validated for all the
countries concerned. (See Table 3)
Discussion
Main Results
These studies are a consecutive stage of the EGPRN project, which aims to provide a compre-
hensive definition of Multimorbidity throughout Europe [16]. The main findings are the trans-
lations of the English definition of multimorbidity into ten European languages (Table 3). The
homogeneity of the translations is of importance for further collaborative research within
EGPRN. The homogeneity of the translations has been evaluated in a semantic, conceptual and
cultural way which confirms that these translations make provision for the cultural background
in which FPs cope with problems in their practices, and demand a holistic approach to the
patient.
Strengths and limitations of the study
The Delphi technique for translation had its own strengths and weaknesses. Nevertheless, it is
seen as an accurate consensus technique in health research [29–30]. It has also been used for
consensus on care processes [31], patient safety measures [32] and detection and referral for
pathologies [33]. There was no information bias in this study as all data was sent to all experts
and group members. There was no selection bias either. Even though the scientific committee
was concerned about the small size of the Bosnian and Spanish-Catalan groups, it was reas-
sured by the homogeneity of their definitions, which were also the most obvious. In some
countries (France and Germany), during the first round, some of the participants believed they
had to evaluate the accuracy of the definition which led to a confusion bias. This bias was dis-
entangled at the beginning of the second round while emphasizing the role of translation as the
only goal of the study. The sample’s characteristics were very carefully followed up in every
country to ensure that the participants were genuine experts, both in Family Medicine and in
use of English.
Key points
A standardized and reproducible definition of multimorbidity is of importance in developed
countries where a larger proportion of the population is elderly. This comprehensive definition
is helpful for targeting resources in a far more accurate way than the WHO definition [6]. In
addition, it gives more focused prognoses for individuals and improves risk management. It
improves clinical decision making, in terms of risk/benefit evaluation. It could help decision-
making when considering the position of an individual on the spectrum of palliative versus ag-
gressive care.
When considering the previous definitions, most authors agreed to reject any concept
which was too vague or insufficiently discriminating for the selection of patients with the
An Homogeneous Definition of Multimorbidity for Research
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Table 3. English Original and ﬁnal translation for each country.
English original Bosnia Bulgaria Croatia
Multimorbidity is deﬁned as any
combination of chronic disease with
at least one other disease (acute or
chronic) or bio-psychosocial factor
(associated or not) or somatic risk
factor. Any bio-psychosocial factor,
any somatic risk factor, the social
network, the burden of diseases,
the health care consumption and
the patient’s coping strategies may
function as modiﬁers (of the effects
of Multimorbidity). Multimorbidity
may modify the health outcomes
and lead to an increased disability
or a decreased quality of life or
frailty.
Multimorbidnost(pacijent sa više
bolesti u isto vrijeme) je deﬁnisana kao
svaka kombinacija bolesti sa najmanje
još jednom nekom bolešću(akutnom ili
hroničnom) ili bio-psihosocijalnim
faktorom koji je udružen ili ne) ili
somatskim faktorom rizika. Svaki bio-
psiho-socijalni faktor,svaki faktor rizika,
socijalna podrška,raširenost bolesti,
korištenje zdravstvene zaštite i način
kako se sam pacijent nosi sa bolešću,
može dovesti do promjene.(efekata
multimorbidnosti). Multimorbidnost-
višebolesnost može mijenjati ishode
zdravlja i voditi povećanoj
nesposobnosti ili sniženom kvalitetu
života ili povećanoj osjetljivosti.
Полиморбидност се определя
като всяка комбинация от
хронично заболяване, с поне едно
друго заболяване (остро или
хронично) или свързан или не със
заболяването био-психо-социален
фактор или друг соматичен
рисков фактор. Всеки био-психо-
социален фактор, всеки рисков
фактор, социалната среда,
тежестта на заболяванията,
използването на здравни услуги и
стратегии на пациента за
справяне могат да оказват
влияние върху ефектите на
полиморбидността.
Полиморбидността може да
доведе до промяна на очакваните
резултати и до по-висока степен
на инвалидност, понижено
качество на живот или слабост.
Multimorbiditet označava bilo koju
kombinaciju kronične bolesti s
barem još jednom bolesti
(akutnom ili kroničnom), ili s
biopsihosocijalnim čimbenikom
(pridruženim ili nepridruženim) ili
sa somatskim čimbenikom rizika.
Bilo koji biopsihosocijalni
čimbenik, bilo koji čimbenik rizika,
društveno okruženje, teret bolesti,
korištenje zdravstvene zaštite te
načini bolesnikova nošenja s
bolešću, mogu djelovati kao
modiﬁkatori (na učinke
multimorbiditeta). Multimorbiditet
može utjecati na zdravstvene
ishode te dovesti do povećanja
nesposobnosti ili do smanjenja
kvalitete života ili do nemoći.
France Germany Greece Italy
La multimorbidité est déﬁnie
comme toute combinaison d’une
maladie chronique avec au moins:
une autre maladie (aiguë ou
chronique) ou un facteur
biopsychosocial (associé ou non)
ou un facteur de risque somatique.
Les effets de la multimorbidité
peuvent être modiﬁés par: tout
facteur biopsychosocial, tout
facteur de risque somatique, le
réseau social, le poids des
maladies, la consommation de
soins de santé et les stratégies
adaptatives du patient. La
multimorbidité peut modiﬁer les
résultats de santé et mener à une
augmentation du handicap ou à
une diminution de la qualité de vie
ou à la fragilité.»
Deﬁniert als jegliche Kombination einer
chronischen Erkrankung mit zumindest
einer weiteren Erkrankung (akut oder
chronisch), oder einem bio-psycho-
sozialen Faktor(assoziiert oder nicht)
oder einem somatischen Risikofaktor.
Jeglicher bio-psycho-soziale Faktor,
jeglicher Risikofaktor, das soziale
Netzwerk, die Krankheitslast, die
Inanspruchnahme des
Gesundheitssystems sowie
persönliche Bewältigungsstrategien
können die Auswirkungen von
Multimorbidität beeinﬂussen.
Multimorbidität kann
Gesundheitsparameter beeinﬂussen
und Funktionseinbußen verstärken.
Sie kann auch die Lebensqualität
reduzieren oder zu Gebrechlichkeit
führen.
Ως πολυνοσσηρότητα ορίζεται κάθε
συνδιασμός οξέων ή χρόνιων
νοσημάτων με ή χωρίς
συσχετιζόμενους ή μη
συσχετιζόμενους
βιοψυχοκοινωνικούς παράγοντες ή
σωματικούς παράγοντες κινδύνου.
Αυτοί οι παράγοντες μπορούν
επίσης να λειτουργήσουν ως
τροποποιητές, παράλληλα με τον
κοινωνικό ιστό, τη χρήση υπηρεσιών
υγείας και τις στρατηγικές
αντιμετώπισης του ασθενούς.
Μπορεί να τροποποιήσει τα
αποτελέσματα στην υγεία και να
οδηγήσει σε μια αυξημένη
ανικανότητα, μια μειωμένη ποιότητα
ζωής ή ευθραστότητα.
Si deﬁnisce multimorbidità ogni
combinazione di una malattia
cronica con almeno un’altra
malattia (acuta o cronica), o un
fattore bio-psicosociale (associato
o meno), o un fattore di rischio
somatico. Ogni fattore bio-
psicosociale, ogni fattore di rischio
somatico, la rete sociale, il carico
delle malattie, l’uso dei servizi
sanitari e le strategie con cui i
pazienti affrontano i loro problemi
possono fungere da agenti
modiﬁcanti (degli effetti di
multimorbidità). La multimorbidità
può modiﬁcare i risultati di salute e
portare ad un incremento della
disabilità o ad un peggioramento
della qualità della vita o a fragilità.
Poland Spain (Castilian) Spain (Catalan)
Wielochorobowość jest deﬁniowana
jako jakiekolwiek połączenie
choroby przewlekłej z przynajmniej
jeszcze jedną chorobą (ostrą lub
przewlekłą) lub z czynnikami bio-
psycho-społecznymi (związanymi z
nią lub nie) lub z czynnikami ryzyka.
Jakikolwiek czynnik bio-psycho-
społeczny, czynnik ryzyka, sieć
społeczna, obciążenie chorobami,
korzystanie z opieki zdrowotnej i
strategie radzenia sobie przez
pacjenta mogą funkcjonować jako
modyﬁkatory. Wielochorobowość
może modyﬁkować wyniki
zdrowotne i prowadzić do
zwiększonej niepełnosprawności
lub obniżenia jakości życia lub
osłabienia.
Se deﬁne multimorbilidad como
cualquier combinación de una
enfermedad crónica con al menos otra
enfermedad (aguda o crónica) o un
factor biopsicosocial (asociado o no) o
un factor de riesgo. Cualquier
determinante bio-psicosocial, cualquier
factor de riesgo, la red social, la carga
producida por las enfermedades, el
uso de recursos sanitarios y las
estrategias de afrontamiento del
paciente pueden actuarcomo
modiﬁcadores del efectos de la
multimorbilidad. La multimorbilidad
puede modiﬁcar los resultados en
salud y conducir a una mayor
discapacidad o una menor calidad de
vida o fragilidad.
Es deﬁneix multimorbiditat com qualsevol combinació d’una malaltia
crònica amb com a mínim una altra malaltia (aguda o crònica) o un
determinant biopsicosocial (associat o no) o un factor de risc. Qualsevol
determinant psicosocial, qualsevol factor de risc, la xarxa social, la
càrrega generada per les malalties, l’ús de recursos sanitaris i les
estratègies d’afrontament del pacient poden funcionar com a
modiﬁcadors dels efectes de multimorbiditat. La multimorbiditat pot
modiﬁcar els resultats en salut i conduir cap a una major discapacitat o
una menor qualitat de vida o fragilitat.
doi:10.1371/journal.pone.0115796.t003
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diseases mentioned. Those caused problems of interpretation, inclusion of patients, induced a
lack of power and confounding factors [34–37]. This comprehensive definition and its transla-
tion into ten European languages encompasses all definitions of multimorbidity found in liter-
ature [16] and will override previous limitations.
The holistic approach and the patient centered care core competencies of Family Medicine,
according to WONCA, [7] promote a concept of multimorbidity which is closer to the result of
this study than any other.
Implications for practice and future research
The purposes of a standardized and reproducible definition of multimorbidity are numerous
and its translation into ten European languages is of great value for further research. A more
comprehensive and homogeneous definition leads to better focused research, especially for
quality of care and cost of care. This study is included in an EGPRN project, which aims to de-
fine the best possible intervention to prevent depression in multimorbid patients. For inclusion
a comprehensive and homogeneous definition of multimorbidity within 11 European lan-
guages (including English) was essential.
Conclusion
This study has finalized, through a careful forward backward translation, including a Delphi
consensus process, ten European, homogeneous translations of the published English Multi-
morbidity definition from the EGPRN. In the light of an increasing number of elderly patients
across Europe, [38–39] introducing these translations and their semantic, conceptual and cul-
tural homogeneity, was a necessary and a relevant step, especially for further research.
The implementation of the new definition is intended to help European FPs to identify
multimorbid patients. It could also be of importance to other Long-Term Care Physicians
(geriatricians for example), as well as policy makers, to plan an optimal management of
patients, and to lower the burden of multimorbidity [40].
The European translations enable the EGPRN research team to proceed to the next step,
which is qualitative research, in order to find the value added by FPs to the concept of multi-
morbidity. This will be achieved by using a grounded theory analysis and a deductive analysis
from the translated definitions of multimorbidity. Then the study’s scientific committee will be
able to discuss which means could be used to ensure the implementations of Multimorbidity
into databases and registers. Eventually an International Classification Primary Care code will
be put forward to the ICPC committee of the WONCA [41].
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